The Central Consumer Protection Authority (CCPA) has imposed a penalty of Rs 10 lakh each on Glaxo Smith Kline and Naaptol for misleading advertisements of their products.
The Central Consumer Protection Authority (CCPA) has imposed a fine of Rs 10 lakh each on GlaxoSmithKline Asia, Naaptol and Sure Vision India for ‘false’ and ‘deceptive’ claims in their advertisements. Their ads have also been de-listed and discontinued.